Vontobel Holding Ltd. Has $207,000 Stake in Bath & Body Works, Inc. (NYSE:BBWI)

Vontobel Holding Ltd. boosted its position in Bath & Body Works, Inc. (NYSE:BBWI) by 24.5% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,494 shares of the company’s stock after purchasing an additional 1,279 shares during the period. Vontobel Holding Ltd.’s holdings in Bath & Body Works were worth $207,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the company. Wellington Management Group LLP raised its holdings in Bath & Body Works by 14.9% in the 4th quarter. Wellington Management Group LLP now owns 131,732 shares of the company’s stock valued at $5,686,000 after buying an additional 17,131 shares during the last quarter. Park Avenue Securities LLC lifted its holdings in shares of Bath & Body Works by 11.0% during the first quarter. Park Avenue Securities LLC now owns 6,700 shares of the company’s stock worth $335,000 after purchasing an additional 666 shares during the period. Sumitomo Mitsui Trust Holdings Inc. lifted its holdings in shares of Bath & Body Works by 1.1% during the first quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 527,415 shares of the company’s stock worth $26,381,000 after purchasing an additional 5,738 shares during the period. Norden Group LLC bought a new stake in shares of Bath & Body Works in the first quarter worth $215,000. Finally, Everett Harris & Co. CA increased its holdings in Bath & Body Works by 3.5% in the first quarter. Everett Harris & Co. CA now owns 48,112 shares of the company’s stock valued at $2,407,000 after purchasing an additional 1,645 shares during the period. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Stock Performance

BBWI stock opened at $29.47 on Thursday. The stock’s 50 day simple moving average is $30.87 and its 200 day simple moving average is $38.23. The company has a market cap of $6.58 billion, a P/E ratio of 7.60, a price-to-earnings-growth ratio of 0.94 and a beta of 1.77. Bath & Body Works, Inc. has a fifty-two week low of $26.20 and a fifty-two week high of $52.99.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.54 billion. Equities analysts predict that Bath & Body Works, Inc. will post 3.18 earnings per share for the current year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 6th. Stockholders of record on Friday, August 23rd were issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.71%. The ex-dividend date was Friday, August 23rd. Bath & Body Works’s dividend payout ratio is currently 20.62%.

Wall Street Analysts Forecast Growth

Several brokerages have commented on BBWI. Evercore ISI cut their target price on Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating on the stock in a report on Wednesday, August 28th. Piper Sandler reduced their target price on Bath & Body Works from $47.00 to $39.00 and set a “neutral” rating on the stock in a report on Thursday, July 11th. The Goldman Sachs Group decreased their target price on shares of Bath & Body Works from $60.00 to $49.00 and set a “buy” rating for the company in a research report on Thursday, August 29th. Morgan Stanley dropped their price target on shares of Bath & Body Works from $56.00 to $51.00 and set an “overweight” rating on the stock in a research report on Thursday, September 5th. Finally, Telsey Advisory Group reiterated an “outperform” rating and set a $42.00 price objective on shares of Bath & Body Works in a research report on Thursday, September 26th. Eight equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, Bath & Body Works currently has a consensus rating of “Moderate Buy” and a consensus target price of $42.35.

Insider Transactions at Bath & Body Works

In other Bath & Body Works news, CEO Gina Boswell purchased 6,000 shares of the company’s stock in a transaction that occurred on Wednesday, October 9th. The shares were acquired at an average price of $29.64 per share, with a total value of $177,840.00. Following the transaction, the chief executive officer now owns 242,987 shares in the company, valued at $7,202,134.68. The trade was a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.27% of the stock is currently owned by insiders.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.